Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit
Nutriband Inc. announced that its CEO, Gareth Sheridan, will participate in the Nasdaq LaB Biotech Summit. The company develops AVERSA™, an abuse-deterrent transdermal technology designed to prevent misuse of drugs such as fentanyl while maintaining patient access. Nutriband is focused on advancing its pipeline and leveraging its intellectual prope…